Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.

Clinical trial NCT03989635 · WITHDRAWN

Trial details

NCT number: NCT03989635
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma Asthma, Bronchial Bronchial Asthma Eosinophilia Physiological Effects of Drugs

Start date: 2019-10-15
Primary completion: 2021-06-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.